✦ LIBER ✦

Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis

✍ Scribed by Sanne Piepers; Jan H. Veldink; Sonja W. De Jong; Ingeborg Van Der Tweel; W-Ludo Van Der Pol; Esther V. Uijtendaal; H. Jurgen Schelhaas; Hans Scheffer; Marianne De Visser; J. M. B. Vianney De Jong; John H. J. Wokke; Geert Jan Groeneveld; Leonard H. Van Den Berg

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 189 KB
Volume: 66
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.21620

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized sequential trial of creatin

A randomized sequential trial of creatine in amyotrophic lateral sclerosis

✍ Geert Jan Groeneveld; Jan H. Veldink; Ingeborg van der Tweel; Sandra Kalmijn; Co 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 2 views

Trial of celecoxib in amyotrophic latera

Trial of celecoxib in amyotrophic lateral sclerosis

✍ Merit E. Cudkowicz; Jeremy M. Shefner; David A. Schoenfeld; Hui Zhang; Katrin I. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

Trial of immunosuppression in amyotrophi

Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation

✍ Lanny J. Haverkamp; R. Glenn Smith; Stanley H. Appel 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB 👁 2 views

A placebo-controlled trial of recombinan

A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis

✍ Dr. Robert G. Miller; Jack H. Petajan; Wilson W. Bryan; Carmel Armon; Richard J. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB

There is no satisfactory treatment for amyotrophic lateral sclerosis (ALS) [ 11. Ciliary neurotrophic factor (CNTF) is an endogenous protein that is released upon injury to the nervous system and limits the extent of injury-induced tieuronal damage in some nerve cells [2, 31. CNTF can be produced in

Aberrant Control of Motoneuronal Excitab

Aberrant Control of Motoneuronal Excitability in Amyotrophic Lateral Sclerosis: Excitatory Glutamate / D-Serine vs. Inhibitory Glycine/γ-Aminobutanoic Acid (GABA)

✍ Jumpei Sasabe; Sadakazu Aiso 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

## Abstract The mechanism underlying selective motoneuronal loss in amyotrophic lateral sclerosis (ALS) remains uncertain. The pathogenesis appears to be a complex and multifactorial process. Glutamate excitotoxicity to motoneuron is one of the most intensely investigated targets for the treatment